Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synthetic MR ABXSAT:SYNT +1.32%63 Median PS Value is kr21.47 as of Jul. 14, 2026, which is 100% below its 10-year median of 0.11. GuruFocus rates XSAT:SYNT with a GF Score™ of 63/100 and a GF Value™ of kr4.59 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 262 Healthcare Providers & Services companies, Synthetic MR AB ranks better than 99.62% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Synthetic MR AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.88. Synthetic MR AB's 10-Year median PS Ratio is 24.3977. Therefore, the Median PS Value for today is kr21.47.
As of today (2026-07-14), Synthetic MR AB's share price is kr0.616. Synthetic MR AB's Median PS Value is kr21.47. Therefore, Synthetic MR AB's Price to Median PS Value for today is 0.03.
The historical rank and industry rank for Synthetic MR AB's Median PS Value or its related term are showing as below:
XSAT:SYNT'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.03 Med: 0.11 Max: 0.4
Current: 0.03
During the past 13 years, the highest Price to Median PS Value of Synthetic MR AB was 0.40. The lowest was 0.03. And the median was 0.11.
XSAT:SYNT's Price-to-Median-PS-Value is ranked better than 99.62% of 262
companies
in the Healthcare Providers & Services industry
Industry Median: 0.71
vs XSAT:SYNT: 0.03
Synthetic MR AB (XSAT:SYNT) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Synthetic MR AB's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.616
/
21.47
=
0.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synthetic MR AB Median PS Value Related Terms
Synthetic MR AB Median PS Value Historical Data
* Premium members only.
The historical data trend for Synthetic MR AB's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:SYNT vs VEEV, BTSG, TEM: Median PS Value Comparison
For the Health Information Services subindustry, Synthetic MR AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synthetic MR AB Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Synthetic MR AB's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Synthetic MR AB's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 24.3977.
Synthetic MR AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.88.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synthetic MR AB (XSAT:SYNT) has a Median PS Value of kr21.47 as of Jul. 14, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Synthetic MR AB and its competitors. This is 19418% above median its historical median of 0.11. Over the past decade, Synthetic MR AB's Median PS Value has ranged from 0.03 to 0.40. According to the industry distribution chart, Synthetic MR AB ranks #1 out of 262 companies in the Healthcare Providers & Services industry, placing it in the top 0.40000000000001%.
Is Synthetic MR AB's Median PS Value too high?
Synthetic MR AB's current Median PS Value of kr21.47 is 19418% above median its 10-year median of 0.11. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.40. Based on the distribution chart, Synthetic MR AB ranks #1 out of 262 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Synthetic MR AB has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Synthetic MR AB's Median PS Value compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Synthetic MR AB ranks #1 out of 262 companies for Median PS Value. This places Synthetic MR AB in the top 0% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.71. Historically, Synthetic MR AB's own Median PS Value has ranged from 0.03 to 0.40 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Synthetic MR AB and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synthetic MR AB's current Median PS Value is kr21.47, which is 19418% above median its own 10-year median of 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthetic MR AB stock overvalued right now?
Based on GuruFocus' analysis, Synthetic MR AB (XSAT:SYNT) is currently considered Possible Value Trap. The stock's GF Value™ is kr4.59, compared to a current price of kr0.62 — trading 86.6% below its estimated fair value. The current Median PS Value is kr21.47, which is 19418% above median its 10-year median of 0.11. Synthetic MR AB's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Synthetic MR AB (XSAT:SYNT), the current Median PS Value is kr21.47 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synthetic MR AB (XSAT:SYNT) Overvalued in 2026?
Based on GuruFocus' analysis, Synthetic MR AB stock appears to be undervalued.
The current stock price of kr0.62 is trading 86.6% below its estimated GF Value™ of kr4.59.
GuruFocus considers Synthetic MR AB to be Possible Value Trap.
Key valuation signals for XSAT:SYNT:
Median PS Value: kr21.47 (19418% above median its 10-year median of 0.11)
GF Value™: kr4.59 vs. price of kr0.62 (86.6% below fair value)
No single metric tells the full story. See the XSAT:SYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
63GF Score
Get the complete analysis for XSAT:SYNT
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:SYNT has been successfully added to your 
